标题
RNA Interference of Human α-Synuclein in Mouse
作者
关键词
-
出版物
Frontiers in Neurology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-01-31
DOI
10.3389/fneur.2017.00013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Viral vectors for therapy of neurologic diseases
- (2017) Sourav R. Choudhury et al. NEUROPHARMACOLOGY
- RNAi prevents and reverses phenotypes induced by mutant human ataxin-1
- (2016) Megan S. Keiser et al. ANNALS OF NEUROLOGY
- α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era
- (2016) Naomi P. Visanji et al. TRENDS IN NEUROSCIENCES
- Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons
- (2015) D. Caudal et al. EXPERIMENTAL NEUROLOGY
- shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
- (2015) Alevtina D. Zharikov et al. JOURNAL OF CLINICAL INVESTIGATION
- Disease-modifying therapeutic directions for Lewy-Body dementias
- (2015) Qiang Zhang et al. Frontiers in Neuroscience
- Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects
- (2014) Christina E. Khodr et al. BRAIN RESEARCH
- Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
- (2014) K. J. Vargas et al. JOURNAL OF NEUROSCIENCE
- Broad Therapeutic Benefit After RNAi Expression Vector Delivery to Deep Cerebellar Nuclei: Implications for Spinocerebellar Ataxia Type 1 Therapy
- (2014) Megan S Keiser et al. MOLECULAR THERAPY
- Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
- (2013) Nandakumar S. Narayanan et al. REVIEWS IN THE NEUROSCIENCES
- Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective
- (2013) Han-Joon Kim Experimental Neurobiology
- Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity
- (2012) Meret Nora Gaugler et al. ACTA NEUROPATHOLOGICA
- α-Synuclein knockout mice have cognitive impairments
- (2012) V.S. Kokhan et al. BEHAVIOURAL BRAIN RESEARCH
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
- (2012) Kelvin C. Luk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
- (2012) Marie-Francoise Chesselet et al. Neurotherapeutics
- siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse
- (2012) Ryan L. Boudreau et al. NUCLEIC ACIDS RESEARCH
- Prefrontal D1 dopamine signaling is required for temporal control
- (2012) N. S. Narayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons
- (2011) Ye Han et al. BRAIN RESEARCH
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease
- (2011) Ryan L Boudreau et al. MOLECULAR THERAPY
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
- (2011) Jodi L McBride et al. MOLECULAR THERAPY
- Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
- (2011) M. Decressac et al. NEUROBIOLOGY OF DISEASE
- Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
- (2010) Shuwen Cao et al. Molecular Neurodegeneration
- In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration
- (2010) Oleg S Gorbatyuk et al. MOLECULAR THERAPY
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
- (2010) Venu M. Nemani et al. NEURON
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Tests to assess motor phenotype in mice: a user's guide
- (2009) Simon P. Brooks et al. NATURE REVIEWS NEUROSCIENCE
- Strengths and limitations of genetic mouse models of Parkinson's disease
- (2008) Marie-Francoise Chesselet et al. PARKINSONISM & RELATED DISORDERS
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
- (2007) Daniel Alvarez-Fischer et al. EXPERIMENTAL NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started